{"id":"W4283376400","doi":"10.1097/01.hs9.0000846460.44039.3d","title":"P897: UPDATED RESULTS FROM THE ONGOING PHASE 1 STUDY OF ELRANATAMAB, A BCMA TARGETED T-CELL REDIRECTING IMMUNOTHERAPY, FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University Health Centre; University of Calgary; Institute of Cancer Research","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Cytokine release syndrome; Adverse effect; Common Terminology Criteria for Adverse Events; Minimal residual disease; Oncology; Transplantation; Immunology; Gastroenterology; Immunotherapy; Cancer; Chimeric antigen receptor; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004335853,0.0003147434,0.0005516502,0.00007482824,0.0006560517,0.00002565924,0.0002927734,0.00006777125,0.0008522149],"category_scores_gemma":[0.0006762192,0.0001919679,0.0001246848,0.0005388227,0.000061485,0.0001093966,0.0001405546,0.0004584501,0.000006106782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002341781,"about_ca_system_score_gemma":0.0002624526,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002016418,"about_ca_topic_score_gemma":0.0005660236,"domain_scores_codex":[0.9969397,0.0003270453,0.0006725276,0.0006284534,0.000932083,0.0005002048],"domain_scores_gemma":[0.9968104,0.001346617,0.0004536983,0.0009177988,0.0003142473,0.0001572487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4575403,0.05355452,0.3115949,0.0002104409,0.004270718,0.0007014046,0.02357503,0.0001630144,0.02640463,0.000002051886,0.01639082,0.1055922],"study_design_scores_gemma":[0.6372588,0.06074689,0.2005176,0.0004088886,0.0007511685,0.00001982841,0.05046181,0.005997847,0.01565669,0.00001373894,0.0272029,0.0009637884],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931073,0.000356312,0.00002923434,0.0001150153,0.0001282879,0.004451683,0.001391356,0.0001053718,0.0003155004],"genre_scores_gemma":[0.9939693,0.0000132686,0.001901446,0.000083573,0.00007355678,0.0005652192,0.002100919,0.00009774903,0.001194971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1797186,"threshold_uncertainty_score":0.9331155,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02427076217442896,"score_gpt":0.291956138476212,"score_spread":0.2676853763017831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}